A Single-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product, Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis

Trial Profile

A Single-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product, Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Santalum album (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions
  • Sponsors Santalis Pharmaceuticals
  • Most Recent Events

    • 08 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2018.
    • 08 Aug 2017 Status changed from recruiting to active, no longer recruiting.
    • 24 Apr 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top